Lista de obras - Ricardo Camacho - Dominio Público Uruguay

A near-full length genotypic assay for HCV1b.

artículo científico publicado en 2014

An automated genotyping system for analysis of HIV-1 and other microbial sequences

artículo científico publicado en 2005

Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance

artículo científico publicado en 2006

Analysis of complex HIV-1 intersubtype recombinants using a Bayesian scanning method

article

Antiretroviral drug resistance in human immunodeficiency virus type 2.

artículo científico publicado en 2009

Antiretroviral resistance in different HIV-1 subtypes: impact on therapy outcomes and resistance testing interpretation

scientific article published on March 2007

Antiretroviral therapy in treatment-naïve patients with HIV infection

artículo científico

Appearance of a single amino acid insertion at position 33 in HIV type 1 protease under a lopinavir-containing regimen, associated with reduced protease inhibitor susceptibility

artículo científico publicado en 2011

Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools

artículo científico publicado en 2013

Bayesian network analyses of resistance pathways against efavirenz and nevirapine

artículo científico publicado en 2008

Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

artículo científico publicado en 2006

Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients

artículo científico publicado en 2010

Characterization of amino acids Arg, Ser and Thr at position 70 within HIV-1 reverse transcriptase.

artículo científico publicado en 2014

Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response

artículo científico publicado en 2013

Comparative performance of the REGA subtyping tool version 2 versus version 1.

artículo científico publicado en 2009

Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes.

artículo científico publicado en 2006

Comparison of the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypes

artículo científico publicado en 2013

Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe ⬇️

artículo científico publicado el 11 de enero de 2013

Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir.

artículo científico publicado en 2012

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study ⬇️

artículo científico publicado el 30 de mayo de 2011

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent

artículo científico publicado en 2006

Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.

artículo científico publicado en 2009

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

artículo científico publicado en 2009

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.

artículo científico publicado en 2009

Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility

artículo científico publicado en 2012

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape

artículo científico publicado en 2010

Estimating the relative contribution of dNTP pool imbalance and APOBEC3G/3F editing to HIV evolution in vivo

artículo científico publicado en 2007

Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment

artículo científico publicado en 2007

Full genome sequence of three isolates of hepatitis C virus subtype 4b from Portugal

artículo científico publicado en 2008

Genetic subtypes of HIV type 1 circulating in Slovakia

artículo científico publicado en 2010

HIV-1 diversity, transmission dynamics and primary drug resistance in Angola

artículo científico publicado en 2014

HIV-1 drug-resistance patterns among patients on failing treatment in a large number of European countries.

artículo científico publicado en 2010

HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure

artículo científico publicado en 2013

HIV-1 genetic variants circulation in the North of Angola

article

HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes

artículo científico publicado en 2006

HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G

article

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

artículo científico publicado en 2013

HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir

artículo científico publicado en 2012

HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen

artículo científico publicado en 2014

HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe

artículo científico publicado en 2013

Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates

artículo científico publicado en 2008

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

artículo científico publicado en 2005

Impact of genetic variation of HIV-1 on drug resistance development

article

Improving the performance of Transposable Elements detection tools

artículo científico publicado en 2013

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

artículo científico publicado en 2014

Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG.

artículo científico publicado en 2006

Limited cross-border infections in patients newly diagnosed with HIV in Europe

artículo científico publicado en 2013

Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.

artículo científico publicado en 2008

Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients

artículo científico publicado en 2011

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.

artículo científico publicado en 2007

Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi

artículo científico publicado en 2006

Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay

artículo científico publicado en 1999

Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.

artículo científico publicado en 2012

Origin and epidemiological history of HIV-1 CRF14_BG.

artículo científico publicado en 2011

Patterns of transmitted HIV drug resistance in Europe vary by risk group

artículo científico publicado en 2014

Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings

artículo científico publicado en 2014

Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon

artículo científico publicado en 2011

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

artículo científico publicado en 2011

Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections

artículo científico publicado en 2014

Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique.

artículo científico publicado en 2013

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

artículo científico publicado en 2005

Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G

article

Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G.

artículo científico publicado en 2005

Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man

article

Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form

artículo científico publicado en 2007

RegaDB: community-driven data management and analysis for infectious diseases

artículo científico publicado en 2013

Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine

artículo científico publicado en 2010

Special Aspects of the Treatment of HIV-2-Infected Patients ⬇️

artículo científico publicado el 24 de enero de 2012

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

article

The demise of multidrug-resistant HIV-1: the national time trend in Portugal

artículo científico publicado en 2012

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal

artículo científico publicado en 2008

The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir

artículo científico publicado en 2008

Time on drug analysis based on real life data

artículo científico publicado en 2014

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

artículo científico publicado en 2009

Transmission of HIV-2

article

Transmission of drug-resistant HIV-1 is stabilizing in Europe

artículo científico publicado en 2009

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

artículo científico publicado en 2012

Updated European recommendations for the clinical use of HIV drug resistance testing

artículo científico publicado en 2004

Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins

artículo científico publicado en 2006

Lista de obras de Ricardo Camacho

A near-full length genotypic assay for HCV1b.

An automated genotyping system for analysis of HIV-1 and other microbial sequences

Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance

Analysis of complex HIV-1 intersubtype recombinants using a Bayesian scanning method

Antiretroviral drug resistance in human immunodeficiency virus type 2.

Antiretroviral resistance in different HIV-1 subtypes: impact on therapy outcomes and resistance testing interpretation

Antiretroviral therapy in treatment-naïve patients with HIV infection

Appearance of a single amino acid insertion at position 33 in HIV type 1 protease under a lopinavir-containing regimen, associated with reduced protease inhibitor susceptibility

Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools

Bayesian network analyses of resistance pathways against efavirenz and nevirapine

Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients

Characterization of amino acids Arg, Ser and Thr at position 70 within HIV-1 reverse transcriptase.

Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response

Comparative performance of the REGA subtyping tool version 2 versus version 1.

Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes.

Comparison of the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypes

Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe ⬇️

Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir.

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study ⬇️

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent

Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.

Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape

Estimating the relative contribution of dNTP pool imbalance and APOBEC3G/3F editing to HIV evolution in vivo

Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment

Full genome sequence of three isolates of hepatitis C virus subtype 4b from Portugal

Genetic subtypes of HIV type 1 circulating in Slovakia

HIV-1 diversity, transmission dynamics and primary drug resistance in Angola

HIV-1 drug-resistance patterns among patients on failing treatment in a large number of European countries.

HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure

HIV-1 genetic variants circulation in the North of Angola

HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes

HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir

HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen

HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe

Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

Impact of genetic variation of HIV-1 on drug resistance development

Improving the performance of Transposable Elements detection tools

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG.

Limited cross-border infections in patients newly diagnosed with HIV in Europe

Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.

Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.

Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi

Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay

Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.

Origin and epidemiological history of HIV-1 CRF14_BG.

Patterns of transmitted HIV drug resistance in Europe vary by risk group

Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings

Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections

Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique.

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G

Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G.

Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man

Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form

RegaDB: community-driven data management and analysis for infectious diseases

Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine

Special Aspects of the Treatment of HIV-2-Infected Patients ⬇️

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

The demise of multidrug-resistant HIV-1: the national time trend in Portugal

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal

The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir

Time on drug analysis based on real life data

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

Transmission of HIV-2

Transmission of drug-resistant HIV-1 is stabilizing in Europe

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

Updated European recommendations for the clinical use of HIV drug resistance testing

Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins